These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1290320)

  • 1. Intravenous therapy of chronic obstructive pulmonary disease with sodium glycinate theophylline monitored by a new bed side theophylline assay.
    Knöbl PN; Burghuber OC
    Acta Med Austriaca; 1992; 19(4):114-7. PubMed ID: 1290320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term therapy with a retard theophylline preparation].
    Keller A; Bömches B; Kandt D
    Fortschr Med; 1995 May; 113(13):197-202. PubMed ID: 7782018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Practicability, effectiveness and tolerance of a standardized prepared theophylline infusion].
    Pohl WR; Kummer F; Lorber H; Würtz J; Aigner K; Pfeiffer KP
    Acta Med Austriaca; 1996; 23(3):105-8. PubMed ID: 8967286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter study with a large number of patients for the validation of pharmacokinetic and clinical findings from controlled studies with small patient cohorts].
    Götz JK; Sauter R
    Pneumologie; 1991 Nov; 45 Suppl 4():867-74. PubMed ID: 1812482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of theophylline in 'irreversible' chronic obstructive pulmonary disease. An update.
    Hill NS
    Arch Intern Med; 1988 Dec; 148(12):2579-84. PubMed ID: 3058071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of two long-acting theophylline preparations in daily evening administration].
    Holzer R
    Wien Med Wochenschr; 1993; 143(2):37-42. PubMed ID: 8488685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tolerance and effect of short-term theophylline infusions].
    Schmidt M
    Pneumologie; 1993 Jan; 47(1):30-5. PubMed ID: 8437976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical functional study of a new delayed-action preparation of "once a day" anhydrous theophylline in patients with chronic obstructive bronchopneumopathy].
    Gatto PG; Bruzzoni A; Valenti V
    Clin Ter; 1989 Jul; 130(1):45-9. PubMed ID: 2529079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum theophylline concentrations and pulmonary function tests after administration of two sustained-release formulations containing theophylline in patients affected by chronic obstructive lung disease.
    Fontana G; Cresci F; Lo Sapio P; Panuccio P
    Int J Clin Pharmacol Res; 1987; 7(5):351-6. PubMed ID: 3667008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Theophylline treatment of irreversible, chronic obstructive pulmonary disease].
    Iversen ET; Eiken PA; Nielsen LM; Laursen LC; Maltbaek N; Tønnesen FV; Rasmussen FV
    Ugeskr Laeger; 1994 Sep; 156(39):5696-9. PubMed ID: 7985256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug monitoring: theophylline--comparison of 3 methods for determination].
    Kropp R; Göbel D
    Pneumologie; 1995 Feb; 49(2):60-4. PubMed ID: 7724504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interactions of theophylline and nifedipine].
    Luther R; Wichert H; Köhler E; Banditt P; Walther H
    Z Erkr Atmungsorgane; 1990; 174(2):97-103. PubMed ID: 2349818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline binding to plasma proteins in patients with chronic obstructive pulmonary disease.
    Calandre EP; Pérez de la Cruz A; Alferez NP; Moreno Carretero E; Hinojosa R; Vázquez Mata G
    Int J Clin Pharmacol Res; 1986; 6(5):397-401. PubMed ID: 3781702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline in the treatment of the elderly with chronic obstructive pulmonary disease.
    Antognozzi G; Buzzo P; Mori M; Ellena S; Triolo A
    Riv Eur Sci Med Farmacol; 1994; 16(3-4):69-72. PubMed ID: 7480962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of theophylline-ethylendiamine on chronic pulmonary arterial hypertension secondary to chronic obstructive pulmonary disease.
    Panuccio P; Viroli L; Chelucci G; Cresci F
    G Ital Cardiol; 1984; 14 Suppl 1():74-6. PubMed ID: 6534771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tolerance of a new oral long-acting theophylline in patients with obstructive airway diseases].
    Nolte D; Dusik B
    Fortschr Med; 1983 Jul; 101(25):1203-6. PubMed ID: 6884955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiological and neuropsychological effects of theophylline in chronic obstructive pulmonary disease.
    Newman D; Tamir J; Speedy L; Newman JP; Ben-Dov I
    Isr J Med Sci; 1994 Nov; 30(11):811-6. PubMed ID: 7982769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Euphylong in patients with chronic obstructive airway diseases].
    Kublik A; von Wichert P
    Pneumologie; 1991 Nov; 45 Suppl 4():858-62. PubMed ID: 1812480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theophylline pharmacokinetics in patients with mild or severe airway obstruction.
    Rizzo A; Mirabella A; Ferrara G; Pipitone P; Bellia V; Bonsignore G
    Bull Eur Physiopathol Respir; 1982; 18(6):811-8. PubMed ID: 6927536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral doxophylline in patients with chronic obstructive pulmonary disease.
    Villani F; De Maria P; Ronchi E; Galimberti M
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):107-11. PubMed ID: 9088999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.